Pulmonary alveolar proteinosis (PAP) is rare. It is characterized by the accumulation of proteinaceous materials in the alveoli. Typical appearance of BAL fluid (BALF) and positive PAS staining of BALF in conjunction with typical clinical and radiographic manifestations may be diagnostic of PAP. The current mainstay of treatment for PAP is whole-lung lavage. Therapy with granulocyte-macrophage colony stimulating factor is also an option. An alternative procedure is selective lobar/segmental lavage by fiberoptic bronchoscopy (FOB).Whole lung lavage with FOB for idiopathic PAP is currently a safe procedure in an experienced setting, and could be considered in patients with less severe lung involvement who cannot tolerate general anesthesia for the whole lung lavage. It provides long-lasting benefits. We report here our experiences with segmental lung lavage by FOB in a patient with vary severe PAP since she could not undergo whole long lavage under general anesthesia. The one year follow up results are also reported.
INTRODUCTION
First reported by Rosen et al, in 1958, pulmonary alveolar proteinosis (PAP) is rare, with a prevalence rate of 0.37 per 100,000 population and a median age at diagnosis of 39 years (1) . It is characterized by the accumulation of proteinaceous materials in the alveoli (1, 2) . The most common symptoms at presentation are dyspnea and cough, rales in 50% of patients, clubbing in 25%, and cyanosis in 21% (1) .
Plain chest radiographs may show alveolar-filling pattern in 62.5% of patients (2, 3) . Infiltrates are mostly diffuse but sometimes show perihilar distribution (1, 2, 3) .
Spirometry and lung volumes may show a mild restrictive ventilatory defect. However, the diffusion capacity for CO (DLCO) is disproportionately and severely reduced (2, 3) .
Patients are mildly hypoxic with increased alveolo-arterial gradients (1, 2, 3) . The serum lactate dehydrogenase (LDH) is mildly elevated (2, 3) . Typical HRCT scan findings for autoimmune PAP patients were ground glass opacities with a patchy geographic pattern, subpleural sparing, crazy-paving appearance, and more involvement of the lower lung field (4) . These findings are rather infrequent At present, the mainstay of treatment of PAP is wholelung lavage (1, 2, 3) . Therapy with granulocyte-macrophage colony stimulating factor is also possible; although its longterm safety has not been determined. An alternative procedure is selected lobar lavage by FOB (5). Whole lung lavage for idiopathic pulmonary alveolar proteinosis is currently a safe procedure in an experienced setting, and provides long-lasting benefits in the majority of patients (6) . In patients and mouse models of PAP, deficient GM-CSF activity appears to result in defective alveolar macrophages that are unable to maintain pulmonary surfactant homeostasis and display defective phagocytic There have been several reports regarding the therapeutic benefits of aeroGM-CSF in patients with PAP , manifested by clinical improvement in symptoms, disease markers, pulmonary function measurements, and radiographic imaging (chest CT scans or chest X ray) (7, 8) .
We would have considered this option for our patient, if other methods of therapy had failed.
CONCLUSION
This experience suggests that bronchoscopic lobar lavage is simple and safe, and may find application in patients in whom a whole-lung lavage with generalized anesthesia is contraindicated, and also in those with less advanced disease in whom proteinaceous substances can be removed with a small volume of lavage fluid.
